Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,242 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07007052RecruitingPhase 2
Tagraxofusp plus venetoclax for newly diagnosed BPDCN
This trial tests a combination of two targeted drugs (tagraxofusp and venetoclax) for people with a rare blood cancer called BPDCN who have not been treated before. The goal is to see if this combination is safe and effective as a first treatment.
AmiensAges 18 years+ - NCT07005453Recruiting
Studying a new way to measure polyp size during colonoscopy
This trial tests a tool that helps doctors more accurately measure the size of polyps found during colonoscopy. Accurate measurement helps decide the best next steps for your care.
Eindhoven, North BrabantAges 55–80 - NCT07012850Enrolling by invitation
MRI for dental and facial injury evaluation
This study uses MRI instead of CT or X-ray to look at injuries to teeth, mouth, and face. It might help find a safer way to image your injury without radiation.
Zurich, Canton of ZurichAges Any age - NCT07010497RecruitingPhase 2
Study of a three-drug combo for advanced liver cancer
This trial tests a new combination of three drugs (Irpagratinib, Atezolizumab, and Bevacizumab) for people with advanced liver cancer that cannot be removed by surgery. It aims to see if this combination is safe and effective.
SeoulAges 19 years+ - NCT07010822RecruitingPhase 3
New Polio Vaccine for Newborns: Gut Protection Study
This study tests giving a new polio vaccine (nOPV2) right after birth to see how well it protects the gut. It is for healthy, full-term newborns whose parents agree to participate.
Chāndpur, Dhaka DivisionAges 1 day–1 week - NCT07007572RecruitingPhase 2
Comparing new tooth implants with different materials
This trial compares two types of tooth implant materials for replacing a missing lower back tooth. It looks at bone health and biting strength to see which material works better.
Cairo, Cairo GovernorateAges 30–60 - NCT07011433Enrolling by invitation
Pneumonia germs, inflammation, and recovery
This study looks at how certain parts of the bacteria that cause pneumonia (called virulence factors) and your body's natural inflammation markers are related to how well you recover. The goal is to learn more about what affects pneumonia outcomes, which could help doctors personalize treatment.
KaunasAges 18 years+ - NCT07007247Enrolling by invitation
Digital aftercare for teens with depression after hospital discharge
This pilot study tests a digital program to support adolescents aged 12–17 with depression after they leave the hospital. It aims to help prevent relapse and improve well-being using a smartphone, tablet, or computer.
HamburgAges 12–17 - NCT07009873Recruiting
Wearable ultrasound sensor trial for heart, leg, or ICU patients
This trial tests a wearable ultrasound sensor that can be stuck to the skin to monitor your heart, leg blood clots, or vital signs in the ICU. It may replace bulky machines and let doctors see your condition more easily and continuously.
Beijing, Beijing MunicipalityAges 18–70 - NCT07007494Recruiting
Early outcomes and nutrition after weight loss surgery
This study looks at how well patients recover after laparoscopic sleeve gastrectomy and how nutritional scores relate to their early outcomes. It may help doctors improve care for people having this common weight loss surgery.
Istanbul, Merkez MahallesiAges 18–65 - NCT07012915Recruiting
Study of Immune Causes of Implant Inflammation
This trial studies severe inflammation around dental implants (peri-implantitis). It aims to understand the immune and tissue changes causing this condition, which may lead to new treatment approaches.
Wroclaw, Lower Silesian VoivodeshipAges 18 years+ - NCT06999031RecruitingEarly Phase 1
CG-105-12 for relapsed/refractory multiple myeloma
This trial tests a new CAR-T cell therapy called CG-105-12 for people with multiple myeloma that has come back or stopped responding to other treatments. It aims to see if this therapy can help when at least 3 prior treatments have failed.
Nanchang, JiangxiAges 18–75 - NCT06618313Recruiting
Testing JCXH-213 for B-cell lymphoma that returned or didn't respond
This trial tests a new treatment called JCXH-213 for people with B-cell non-Hodgkin lymphoma that came back or didn't get better after previous treatment. It aims to see if the treatment is safe and works against the cancer.
BeijingAges 18 years+ - NCT06996080RecruitingPhase 3
Study of KSI-101 for swelling caused by eye inflammation
This trial tests a new medicine called KSI-101 given as an injection into the eye to treat swelling in the center of the retina caused by inflammation. It may help people whose vision has gotten worse due to this type of swelling.
Phoenix, ArizonaAges 18 years+ - NCT06994650RecruitingPhase 3
Study of HRS9531 for sleep apnea and obesity
This trial tests an injection called HRS9531 to see if it helps people with obstructive sleep apnea (OSA) and obesity who already use a CPAP or similar breathing device. It may help by reducing weight and improving breathing during sleep.
Beijing, Beijing MunicipalityAges 18–75 - NCT06997003Recruiting
Study of a new laser for vision correction
This study tests a new laser (called TENEO 317 Model 2) for vision correction. If you're already scheduled for LASIK to fix nearsightedness or farsightedness (with or without astigmatism), you may be eligible. The study checks if this new laser is safe and works well.
Zlín, Czech RepublicAges 18 years+ - NCT06995482RecruitingPhase 1
Testing safety of KSHN001034 in healthy postmenopausal women
This study tests how safe and tolerable a new drug, KSHN001034, is in healthy women who have gone through menopause. It involves multiple doses to see how your body processes the medicine.
Miami Lakes, FloridaAges 45–60 - NCT07002177RecruitingPhase 1/Phase 2
Combination therapy study for ER+/HER2- breast cancer
This trial tests a new drug called FWD1802 combined with other treatments for people with a certain type of advanced breast cancer (ER-positive, HER2-negative). It aims to find better options if standard treatments have stopped working or aren't suitable.
ShanghaiAges 18–75 - NCT06999590RecruitingPhase 4
Testing wound-healing products for stubborn bedsores
This trial tests different wound-healing products (called CAMPs) to see if they work better than standard care for hard-to-heal pressure ulcers (bedsores). It might be a good fit if you have a long-lasting stage 3 or 4 bedsore on your trunk that is not infected.
Monroeville, PennsylvaniaAges 18 years+ - NCT06997627RecruitingPhase 1/Phase 2
Safety and immune response study of GC3111B vaccine in healthy adults
This trial tests a new vaccine called GC3111B to see if it is safe and helps the body build protection against diphtheria, tetanus, and pertussis (whooping cough). It is for healthy adults who have not had a similar vaccine in the last 2 years.
SeoulAges 19–64 - NCT06880354RecruitingPhase 1
Dual-target CAR-T cells for relapsed or refractory AML
This study tests a new CAR-T cell therapy that targets two proteins, CLL1 and CD38, on leukemia cells. It is designed for people whose acute myeloid leukemia has returned or not responded to treatment.
TianjinAges 18–70 - NCT07001917Enrolling by invitation
MRI to check pancreas and kidney transplant health
This study uses MRI scans to see how well your new pancreas and kidney are working after transplant. It may help doctors monitor your transplant without needing risky procedures.
Wuhan, HubeiAges Any age - NCT06996067Recruiting
Parent coaching texts after first baby in Nova Scotia
This trial tests a text message program to support new parents after childbirth. It aims to help you feel more confident and connected during the early weeks at home.
Halifax, Nova ScotiaAges 18 years+ - NCT06994754Recruiting
Expanding the upper jaw with clear aligners in cleft lip and palate patients
This trial tests whether clear aligners can safely widen the upper jaw in children with cleft lip and palate who still have some baby teeth. It may be an option for those needing jaw expansion without braces.
Cairo, SelectAges 6–12
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,242 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.